IGFBP7 and cardiac arrest: Further, GWAS studies have identified mutations in IGFBP7 associated with diastolic blood pressure [60], cardiac arrest [61] and gestational diabetes [62], mutations in ITGA1 associated with platelet count [63], lymphocyte count [61], and LDL measurement [61], and mutations in VCAN associated with monocyte count [64], triglyceride level [65, 66], and HDL measurements [67].